Omnicell Announces Voluntary Dismissal of Shareholder Lawsuit
With the dismissal of the Nelson lawsuit, no pending class action lawsuits are outstanding, following the resolution of
More than 3,000 customers worldwide have utilized Omnicell Automation and Analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Medication Adherence solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/omnicell-announces-voluntary-dismissal-of-shareholder-lawsuit-300089636.html
News Provided by Acquire Media